The LPPFusion Board of Advisors met on Saturday, Jan 28 and took the following unanimous decisions:
The existing Reg D offering, available to accredited investors, will be extended on the same terms ($2.4 million total, $200/share) until June 30, 2023. The Board alerts investors that in the event of major new results for our lab, the offering may be terminated before June 30 and another offering started at a higher price.
A new crowdfunding offering will be initiated as soon as new informational materials are completed in March. This offering will also be at the existing $200/share price.
On the basis of this BOA decision, LPPFusion is now raising $100,000 as minimum goal from accredited investors by March 31. We need this money to maintain our progress in the lab (see story below) . We urge investors to do their part to keep us rolling toward Focus Fusion as rapidly as possible. We also feel that with the new credibility generated by our peer-reviewed paper, the fund drive presents a great opportunity for investors to buy shares at our existing price.
We will be announcing the goals for the crowdfunding offering soon.